Efficacy and Safety of Angiotensin Receptor Neprilysin Inhibitor versus Angiotensin Converting Enzyme Inhibitor in Heart Failure with Reduced Ejection Fraction- A Prospective Observational Study from a Major Tertiary Care Hospital, Assam, India

Efficacy and Safety of Angiotensin Receptor Neprilysin Inhibitor versus Angiotensin Converting Enzyme Inhibitor in Heart Failure with Reduced Ejection Fraction- A Prospective Observational Study from a Major Tertiary Care Hospital, Assam, India

Introduction: Angiotensin Receptor Neprilysin Inhibitor (ARNI) has shown to reduce morbidity and mortality in comparison to Angiotensin Converting Enzyme Inhibitors (ACEI) inpatients of Heart Failure with Reduced Ejection Fraction (HFrEF). However, the use of ARNI in real-world practice is limited a...

Full description

Bibliographic Details
Main Authors: Bornali Dutta, Waseem Farooqui, Farhin Iqbal
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2022-10-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
health related quality of life
mortality
ramipril
risk of death
sacubitril/valsartan
Online Access:https://jcdr.net/articles/PDF/17049/58399_CE(AD)_F[SH]_PF1(SC_SHU)_PFA(SS)_PB(SC_SS)_PN(SS).pdf

Similar Items

Similar Items